[Overadditive synergism of combinations of cyclophosphamide with thymidine, adenosine or uridine in transplantation tumors].
D000241:Adenosine / Q000008:administration & dosage* / Q000627:therapeutic use; D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D012510:Sarcoma 180 / Q000188:drug therapy; D013936:Thymidine / Q000008:administration & dosage* / Q000627:therapeutic use; D013997:Time Factors; D014529:Uridine / Q000008:administration & dosage* / Q000627:therapeutic use
D003520:Cyclophosphamide; D000241:Adenosine; D013936:Thymidine; D014529:Uridine
Uberadditiver Synergismus einer Kombination von Cyclophosphamid mit Thymidin, Adenosin oder Uridin bei Transplantationstumoren.